Last updated on April 2019

Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors Non-Hodgkin Lymphoma or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial)


Brief description of study

This phase II Pediatric MATCH trial studies how well vemurafenib works in treating patients with solid tumors, non-Hodgkin lymphoma, or histiocytic disorders with BRAF V600 mutations that have spread to other places in the body and have come back or do not respond to treatment. Vemurafenib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

Detailed Study Description

PRIMARY OBJECTIVES:

I. To determine the objective response rate (ORR; complete response + partial response) in pediatric patients treated with vemurafenib with advanced solid tumors (including central nervous system [CNS] tumors), lymphomas or histiocytic disorders that harbor activating BRAF V600 mutations.

SECONDARY OBJECTIVES:

I. To estimate the progression free survival in pediatric patients treated with vemurafenib with advanced solid tumors (including CNS tumors), lymphomas or histiocytic disorders that harbor activating BRAF V600 mutations.

II. To obtain information about the tolerability of vemurafenib in children with relapsed or refractory cancer.

TERTIARY OBJECTIVES:

I. To explore approaches to profiling changes in tumor genomics over time through evaluation of circulating tumor deoxyribonucleic acid (DNA).

OUTLINE

Patients receive vemurafenib orally (PO) twice daily (BID) on day 1-28. Courses repeat every 28 days for up to 2 years in the absence of disease progression or unacceptable toxicity.

Clinical Study Identifier: NCT03220035

Contact Investigators or Research Sites near you

Start Over

Children's Hospital of Alabama

Birmingham, AL United States
  Connect »

Arkansas Children's Hospital

Little Rock, AR United States
  Connect »

Children's Hospital Los Angeles

Los Angeles, CA United States
  Connect »

Kaiser Permanente-Oakland

Oakland, CA United States
  Connect »

Nemours Children's Hospital

Orlando, FL United States
  Connect »

Riley Hospital for Children

Indianapolis, IN United States
  Connect »

Blank Children's Hospital

Des Moines, IA United States
  Connect »

Ochsner Medical Center Jefferson

New Orleans, LA United States
  Connect »

Mercy Hospital Saint Louis

Saint Louis, MO United States
  Connect »

University of Rochester

Rochester, NY United States
  Connect »

Cleveland Clinic Foundation

Cleveland, OH United States
  Connect »

Seattle Children's Hospital

Seattle, WA United States
  Connect »

C S Mott Children's Hospital

Ann Arbor, MI United States
  Connect »

Cook Children's Medical Center

Fort Worth, TX United States
  Connect »

Yale University

New Haven, CT United States
  Connect »

Sinai Hospital of Baltimore

Baltimore, MD United States
  Connect »

UCSF Medical Center-Mission Bay

San Francisco, CA United States
  Connect »

Norton Children's Hospital

Louisville, KY United States
  Connect »

Mayo Clinic

Rochester, MN United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.